Literature DB >> 2999985

Gene expression in mice after high efficiency retroviral-mediated gene transfer.

M A Eglitis, P Kantoff, E Gilboa, W F Anderson.   

Abstract

A retroviral expression vector (N2) containing the selectable gene, neoR, has been used to determine the optimal conditions for infecting murine hematopoietic progenitor cells at high efficiency. After infected bone marrow cells were introduced into lethally irradiated mice, the presence, stability, and expression of the vector DNA sequences were analyzed either in individual spleen foci 10 days later or in the blood, bone marrow, and spleens of mice 4 months later. When bone marrow cells were cultured in medium containing virus with titers of more than 10(6) colony-forming units per milliliter in the presence of purified murine interleukin-3, more than 85 percent of the resulting foci contained vector DNA. This proviral vector DNA was intact. Efficient expression of the neoR gene was demonstrated in most of the DNA-positive foci examined. The spleens of reconstituted animals (over a long term) contained intact "vector DNA" and the blood and bone marrow expressed the neoR gene in some animals. Thus, a retroviral vector can be used to introduce intact exogenous DNA sequences into hematopoietic stem cells with high efficiency and with substantial expression.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999985     DOI: 10.1126/science.2999985

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  70 in total

1.  Somatic cell mutants resistant to retrovirus replication: intracellular blocks during the early stages of infection.

Authors:  G Gao; S P Goff
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

2.  Capillary endothelial cell tropism of PVC-211 murine leukemia virus and its application for gene transduction.

Authors:  M Masuda; C A Hanson; N V Dugger; D S Robbins; S G Wilt; S K Ruscetti; P M Hoffman
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Development of avian sarcoma and leukosis virus-based vector-packaging cell lines.

Authors:  A W Stoker; M J Bissell
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

4.  Enhancer sequences of a retroviral vector determine expression of a gene in multipotent hematopoietic progenitors and committed erythroid cells.

Authors:  C A Holland; P Anklesaria; M A Sakakeeny; J S Greenberger
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells.

Authors:  D M Bodine; S Karlsson; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

6.  Differential effects of microenvironmentally presented interleukin 3 versus soluble growth factor on primitive human hematopoietic cells.

Authors:  T Otsuka; J D Thacker; C J Eaves; D E Hogge
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

7.  Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice.

Authors:  M A Eglitis; E Mezey
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 8.  Retroviral vectors: from cancer viruses to therapeutic tools.

Authors:  A Dusty Miller
Journal:  Hum Gene Ther       Date:  2014-12       Impact factor: 5.695

9.  Expression of human alpha-globin and mouse/human hybrid beta-globin genes in murine hemopoietic stem cells transduced by recombinant retroviruses.

Authors:  C L Li; V J Dwarki; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

10.  Transfer and expression of the human multiple drug resistance gene into live mice.

Authors:  S Podda; M Ward; A Himelstein; C Richardson; E de la Flor-Weiss; L Smith; M Gottesman; I Pastan; A Bank
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.